603367 沪市 辰欣药业

  证券代码：603367    证券简称：辰欣药业      公告编号：2022-058

                    辰欣药业股份有限公司

                  2022年半年度经营数据公告

  本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者

  重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。

      根据《上市公司行业信息披露指引第六号—医药制造》、《关于做好上市公

  司2022年半年度报告披露工作的通知》的要求，辰欣药业股份有限公司（以下简

  称“公司”）现将2022年半年度主要经营数据(未经审计)披露如下：

  1、主营业务按产品分类：

                                                            单位:元 币种:人民币

 分产品      营业收入        营业成本    毛利率  营业收入比  营业成本比  毛利率比
                                                      上年增减    上年增减  上年增减

大输液-    173,757,258.43    97,065,913.07  44.14%      -13.24%      -2.88%    -5.96%
玻瓶
大输液-

非 PVC    367,623,107.44  131,476,257.27  64.24%      -8.22%      -1.34%    -2.49%
软包

大输液-    354,153,023.34  239,964,174.13  32.24%        8.29%      3.12%    3.40%
塑瓶

小容量    448,619,112.78  186,613,468.01  58.40%      25.46%      34.67%    -2.84%
注射剂

口服固    213,675,087.83    86,206,068.09  59.66%        3.53%      24.25%    -6.73%
体制剂

冻干粉      65,393,556.07    28,468,547.74  56.47%      -15.13%      -2.46%    -5.65%
针剂

冲洗剂      9,005,400.55    3,552,926.73  60.55%    3328.19%    3959.48%    -6.14%

滴剂        98,126,497.35    24,291,455.97  75.24%        0.34%      1.91%    -0.38%

膏剂        76,260,952.04    20,986,901.00  72.48%        3.12%      14.76%    -2.79%

原料（自    53,803,502.68    21,414,636.47  60.20%      -37.37%    -16.07%  -10.10%
产外销）

合计    1,860,417,498.51  840,040,348.48  54.85%        1.84%      8.98%    -2.96%

  2、主营业务按地区分类：

                                                            单位:元 币种:人民币

 分地区      营业收入        营业成本    毛利率  营业收入比  营业成本比  毛利率比
                                                      上年增减    上年增减  上年增减

国内地  1,842,056,113.90  824,009,706.10  55.27%      4.20%      10.68%    -2.62%
区


国外地      18,361,384.61    16,030,642.38  12.69%    -68.93%    -39.06%  -42.79%
区

合计    1,860,417,498.51  840,040,348.48  54.85%      1.84%      8.98%    -2.96%

  3、主营业务按销售模式分类

                                                          单位:元 币种:人民币

 销售模      营业收入        营业成本      毛利率  营业收入比  营业成本比  毛利率比
  式                                                  上年增减    上年增减  上年增减

直销      132,554,562.09    52,575,365.21  60.34%    -29.50%    -22.35%    -3.65%

经销    1,727,862,936.42  787,464,983.27  54.43%      5.43%      12.00%    -2.67%

合计    1,860,417,498.51  840,040,348.48  54.85%      1.84%      8.98%    -2.96%

  4、主营业务按治疗领域或主要药（产）品等分类

                                                          单位:元 币种:人民币

 治疗        营业            营业        毛利率  营业收入比  营业成本比  毛利率比
 领域        收入            成本                上年增减    上年增减  上年增减

营养型    296,783,115.14    125,084,884.60  57.65%    -15.32%      -9.41%    -2.77%
输液

普通输    532,994,853.68    287,491,336.97  46.06%      10.92%      7.46%    1.73%
液

抗感染    253,379,033.11    134,840,195.51  46.78%      16.01%      15.82%    0.09%
类

心脑血    214,607,412.48    79,172,673.41  63.11%    -21.29%      20.65%  -12.83%
管类

肝病用    12,041,697.67    1,934,218.25  83.94%    -11.59%      -4.56%    -1.18%
药

消化系    36,792,275.55    11,180,332.91  69.61%      40.26%      3.10%    10.95%
统用药
抗肿瘤

及其辅    56,326,276.99    6,881,610.94  87.78%    -24.60%    -17.30%    -1.08%
助用药

其他类    403,689,331.21    172,040,459.41  57.38%      32.68%      26.71%    2.01%
药物

原料药    53,803,502.68    21,414,636.47  60.20%    -37.37%    -16.07%  -10.10%

合计    1,860,417,498.51    840,040,348.48  54.85%      1.84%      8.98%    -2.96%

  特此公告。

                                                  辰欣药业股份有限公司

                                                                董事会

                                                      2022年 8 月 22 日